看到Genfit网页上在主要临床终点未达到下面还跟了一段，简直是近些年看到最悲伤的临床结果之一了，大写的一个“死”字 No significant differences as compared to placebo were achieved on the key secondary endpoints, including fibrosis improvement of at least one stage and changes in metabolic parameters (triglycerides, Non-HDL Cholesterol, HDL Cholesterol, LDL Cholesterol, HOMA-IR in non diabetic patients, and HbA1c in diabetic patients).